American Heart Association Scientific Sessions 2020

Blacks, Hispanics Had Higher Rates of Hospitalization, Mortality from COVID-19

According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of hospitalizations...
High Dose Flu Shot More Effective in RA Patients 

High-Dose Influenza Vaccine Similar to Standard-Dose for All-Cause Death, Cardiopulmonary Events

High-dose inactivated influenza vaccine did not reduce all-cause death or hospitalization for cardiopulmonary causes compared with a standard-dose vaccine in patients with high-risk cardiovascular...
Rivaroxaban Plus Aspirin Lowers Vs. Aspirin Alone in Those With Prior PCI

Rivaroxaban Plus Aspirin Reduced Cardiac, Limb Events in PAD After LER

Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after lower extremity revascularization (LER), according to...
Doctor examing clip board

Rivaroxaban Monotherapy Safe for AF After Coronary Stenting

The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent on the duration of time from stenting, according...
Doctors with Clipboard

40% of Middle-Aged Swedes Had Silent CAD

Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having severe CAD, according...
Evolocumab Associated with Reduced Risk for Complex Revascularization

Rates of Thromboembolic Complications High in COVID-19+ ICU Patients

Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), major adverse cardiovascular events, and...
A mid adult male doctor sits at a table across from an unrecognizable patient. He holds up a prescription bottle as he explains the benefits and risks of a new medication.

Rivaroxaban Plus Aspirin Protects Against Venous, Arterial Thrombotic Events After LER

Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism (VTE) after lower extremity revascularization (LER). Low-dose rivaroxaban plus...

Recent Cardiology Headlines

Cardio Round-Up: Heart Transplants from Past Drug Users Safe; The ABC's of CVD Prevention; and More

Cardio Round-Up: Heart Transplants from Past Drug Users Safe; The ABC’s of CVD Prevention;...

Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival Rates Heart transplant recipients have unaffected survival rates if they receive...
Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival Rates

Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival...

Heart transplant recipients have unaffected survival rates if they receive a transplant from an organ donor who used illicit drugs or died due to...
AFib in Hospitalized COVID-19 Patients Associated with a Two-Fold Risk of Dying

AFib in Hospitalized COVID-19 Patients Associated with a Two-Fold Risk of Dying

A study shows that about one in ten hospitalized patients with SARS-CoV-2 (COVID-19) have atrial fibrillation (AFib), and these patients suffer more comorbidities and...
Risk Factors ID'd for VTE, ASCVD in Rheumatoid Arthritis Patients

Risk Factors ID’d for VTE, ASCVD in Rheumatoid Arthritis Patients

For patients with rheumatoid arthritis, there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD...